ピーク情報
|
イネ 玄米 コシヒカリ
pos
|
| Peak #3298 MN MID: SE199_S11_M90 |
| m/z: 353.23222, RT: 44.87, 強度: 1152, ログ強度: -0.37, アダクト: [M+H]+, 共有数（同様のピークを含むサンプル数）: 2 |
| DB検索結果: (80 names) Prostaglandin I2;14S,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid;Levuglandin E2;Prostaglandin H2;13,14-Dihydro-15-oxo-lipoxin A4;(5S,9R)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic... |
| DBごとのヒット数: ALL 70 KG 17 KN 26 HM 4 LM 23 |
| FlavonoidSearch最大スコア MS2: 0.100, MS3: - |
DB検索結果
ppm
| 組成式 | 分子量 | 誤差(Δppm） | 候補化合物名（代表で最短名を記載） | 化合物ID |
|---|---|---|---|---|
| C20H32O5 | 352.22497 | -0.077 | Prostaglandin I2 | HMDB: HMDB0001335, HMDB0246193 KEGG: C01312 LipidMAPS: LMFA03010087 |
| C20H32O5 | 352.22497 | -0.077 | 14S,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid | LipidMAPS: LMFA03000030, LMFA03000029 |
| C20H32O5 | 352.22497 | -0.077 | Levuglandin E2 | HMDB: HMDB0002363 KEGG: C13807 LipidMAPS: LMFA03100001, LMFA03100004, LMFA03100005, LMFA03100006, LMFA03100007, LMFA03100008 |
| C20H32O5 | 352.22497 | -0.077 | Prostaglandin H2 | HMDB: HMDB0001381 KEGG: C00427 LipidMAPS: LMFA03010010 |
| C20H32O5 | 352.22497 | -0.077 | 8,9 | LipidMAPS: LMFA03000035 |
| C20H32O5 | 352.22497 | -0.077 | 13,14-Dihydro-15-oxo-lipoxin A4 | HMDB: HMDB0012564, HMDB0062291 LipidMAPS: LMFA03040008, LMFA03050025 |
| C20H32O5 | 352.22497 | -0.077 | [6]-Gingerdiol acetate methyl ether | HMDB: HMDB0303098 |
| C20H32O5 | 352.22497 | -0.077 | (5S,9R)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | LipidMAPS: LMFA03100025, LMFA03100026, LMFA03100027, LMFA03100028 |
| C20H32O5 | 352.22497 | -0.077 | Sinuflexolide | KNApSAcK: C00050234 |
| C20H32O5 | 352.22497 | -0.077 | 2,3-Dicarboxy-2,3-secomanoyl oxide | KNApSAcK: C00023368 |
| C20H32O5 | 352.22497 | -0.077 | 6R,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R] | LipidMAPS: LMFA03110078, LMFA03110079, LMFA03110080, LMFA03110081, LMFA03110082, LMFA03110083, LMFA03110084, LMFA03110085, LMFA03110237, LMFA03110238, LMFA03110239, LMFA03110240, LMFA03110241, LMFA03110242, LMFA03110243, LMFA03110244 |
| C20H32O5 | 352.22497 | -0.077 | 14-Deoxy-17-hydroxyandrographolide | KNApSAcK: C00041244 |
| C20H32O5 | 352.22497 | -0.077 | Neorustmicin C | KNApSAcK: C00017785 |
| C20H32O5 | 352.22497 | -0.077 | (E,Z,E)-1,16-Dihydroxy-3,11-bis(hydroxymethyl)-15-methyl-7-methylene-2,10,14-hexadecatrien-6-one | KNApSAcK: C00022121 |
| C20H32O5 | 352.22497 | -0.077 | Leopersin J | KNApSAcK: C00050317, C00050377 |
| C20H32O5 | 352.22497 | -0.077 | 5-hydroperoxy-15-HETE | HMDB: HMDB0062798 |
| C20H32O5 | 352.22497 | -0.077 | Cinncassiol D1 | HMDB: HMDB0034676 KEGG: C17652 KNApSAcK: C00055045 |
| C20H32O5 | 352.22497 | -0.077 | 5R,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R] | LipidMAPS: LMFA03110064, LMFA03110065, LMFA03110066, LMFA03110067, LMFA03110068, LMFA03110069, LMFA03110070, LMFA03110077, LMFA03110229, LMFA03110230, LMFA03110231, LMFA03110232, LMFA03110233, LMFA03110234, LMFA03110235, LMFA03110236 |
| C20H32O5 | 352.22497 | -0.077 | Prostaglandin E2 | HMDB: HMDB0001220, HMDB0005844, HMDB0060041, HMDB0247796, HMDB0302207 KEGG: C00584 LipidMAPS: LMFA03010003, LMFA03010060, LMFA03010094, LMFA03010148, LMFA03110003, LMFA03110106, LMFA03110115, LMFA03110116, LMFA03110117, LMFA03110120, LMFA03110121, LMFA03110122, LMFA03110124, LMFA03110125, LMFA03110126, LMFA03110127 |
| C20H32O5 | 352.22497 | -0.077 | 11S,14R,15S-trihydroxyeicosa-5Z,8Z,12E,17Z-tetraenoic acid | LipidMAPS: LMFA03060121 |
| C20H32O5 | 352.22497 | -0.077 | Albopilosin E | KNApSAcK: C00042211 |
| C20H32O5 | 352.22497 | -0.077 | Grayanotoxin II | KNApSAcK: C00043548 LipidMAPS: LMPR0104180001 |
| C20H32O5 | 352.22497 | -0.077 | (8S,12R)-9,10-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | LipidMAPS: LMFA03100033, LMFA03100034, LMFA03100035, LMFA03100036 |
| C20H32O5 | 352.22497 | -0.077 | [1R-[1R*,4R*,6R*,7R*(Z),8R*,11R*]]-8-(1-Hydroxy-1-methylethyl)-4,11-dimethyl-5,12-dioxatricyclo[9.1.0.04,6]dodec-7-yl ester 2-methyl-2-butenoic acid | KNApSAcK: C00012063 |
| C20H32O5 | 352.22497 | -0.077 | 4-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid | LipidMAPS: LMFA03110187, LMFA03110188, LMFA03110189, LMFA03110190, LMFA03110191, LMFA03110192, LMFA03110193, LMFA03110194, LMFA03110195, LMFA03110196, LMFA03110197, LMFA03110198, LMFA03110199, LMFA03110200, LMFA03110201, LMFA03110202 |
| C20H32O5 | 352.22497 | -0.077 | Cinncassiol D4 | HMDB: HMDB0035064 KEGG: C17656 KNApSAcK: C00055043 |
| C20H32O5 | 352.22497 | -0.077 | Manaarenolide C | KNApSAcK: C00041651, C00041652 |
| C20H32O5 | 352.22497 | -0.077 | Sterebin B | HMDB: HMDB0035338 KNApSAcK: C00023383 |
| C20H32O5 | 352.22497 | -0.077 | Sterebin C | HMDB: HMDB0035339 KNApSAcK: C00023384 |
| C20H32O5 | 352.22497 | -0.077 | 9S,15S-dihydroxy-11-oxo-5Z,12E-prostadienoic acid | LipidMAPS: LMFA03010101 |
| C20H32O5 | 352.22497 | -0.077 | (11S,15R)-13,14-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | LipidMAPS: LMFA03100013, LMFA03100014, LMFA03100015, LMFA03100016 |
| C20H32O5 | 352.22497 | -0.077 | Prostaglandin F3alpha | HMDB: HMDB0002122, HMDB0002132 KEGG: C06476 LipidMAPS: LMFA03010138, LMFA03110007 |
| C20H32O5 | 352.22497 | -0.077 | Strictanonoic acid | KNApSAcK: C00022643 |
| C20H32O5 | 352.22497 | -0.077 | Neorustmicin D | KNApSAcK: C00017786 |
| C20H32O5 | 352.22497 | -0.077 | (8S,12R)-10,11-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid | LipidMAPS: LMFA03100017, LMFA03100018, LMFA03100019, LMFA03100020 |
| C20H32O5 | 352.22497 | -0.077 | 9-oxo-11R,15S-dihydroxy-13E,17Z-prostadienoic acid | LipidMAPS: LMFA03010143 |
| C20H32O5 | 352.22497 | -0.077 | Lipoxin B4 | HMDB: HMDB0005082, HMDB0247662 KEGG: C06315 LipidMAPS: LMFA01030749, LMFA03040002, LMFA03040007 |
| C20H32O5 | 352.22497 | -0.077 | 13,14-Dihydro-15-keto-PGD2 | HMDB: HMDB0060042, HMDB0244513 LipidMAPS: LMFA03010022 |
| C20H32O5 | 352.22497 | -0.077 | (ent-6alpha,7alpha,16alphaH)-6,7,17-Trihydroxy-19-kauranoic acid | HMDB: HMDB0036756 |
| C20H32O5 | 352.22497 | -0.077 | (R,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid | LipidMAPS: LMFA03110171, LMFA03110172, LMFA03110173, LMFA03110174, LMFA03110175, LMFA03110176, LMFA03110177, LMFA03110178, LMFA03110179, LMFA03110180, LMFA03110181, LMFA03110182, LMFA03110183, LMFA03110184, LMFA03110185, LMFA03110186 |
| C20H32O5 | 352.22497 | -0.077 | Levuglandin D2 | HMDB: HMDB0002400 KEGG: C13808 LipidMAPS: LMFA03100002, LMFA03100003, LMFA03100021, LMFA03100022, LMFA03100023, LMFA03100024 |
| C20H32O5 | 352.22497 | -0.077 | Leopersin C | KNApSAcK: C00031972 |
| C20H32O5 | 352.22497 | -0.077 | (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate | HMDB: HMDB0001320, HMDB0062691 KEGG: C04654 LipidMAPS: LMFA03010146 |
| C20H32O5 | 352.22497 | -0.077 | 8R,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R] | LipidMAPS: LMFA03110050, LMFA03110051, LMFA03110052, LMFA03110053, LMFA03110054, LMFA03110055, LMFA03110056, LMFA03110057, LMFA03110221, LMFA03110222, LMFA03110223, LMFA03110224, LMFA03110225, LMFA03110226, LMFA03110227, LMFA03110228 |
| C20H32O5 | 352.22497 | -0.077 | Leucasperol A | KNApSAcK: C00041625, C00041626 |
| C20H32O5 | 352.22497 | -0.077 | Prostaglandin D2 | HMDB: HMDB0001403 KEGG: C00696 LipidMAPS: LMFA03010004, LMFA03010102, LMFA03110092, LMFA03110093, LMFA03110094, LMFA03110095, LMFA03110096, LMFA03110097, LMFA03110098, LMFA03110099, LMFA03110107, LMFA03110128, LMFA03110129, LMFA03110130, LMFA03110131, LMFA03110132 |
| C20H32O5 | 352.22497 | -0.077 | (5E,8E,11E)-12-{(1'R,2'S,3'S,5'S)-2',3'-dihydroxy-5'-[(1''R)-1''-hydroxypropyl]cyclopentyl}-5,8,11-dodecatrienoic acid | LipidMAPS: LMFA04000106 |
| C20H32O5 | 352.22497 | -0.077 | 15R-hydroxy-12S,14R-dioxolane-5Z,8Z,10E-eicosatrienoic acid | LipidMAPS: LMFA03150002 |
| C20H32O5 | 352.22497 | -0.077 | 9,11-dioxo-15S-hydroxy-13E-prostenoic acid | LipidMAPS: LMFA03010170 |
| C20H32O5 | 352.22497 | -0.077 | Capillolide | KNApSAcK: C00038695 |
| C20H32O5 | 352.22497 | -0.077 | Wightionolide | KNApSAcK: C00023363 |
| C20H32O5 | 352.22497 | -0.077 | 15-Keto-prostaglandin F2alpha | HMDB: HMDB0004240, HMDB0005077 KEGG: C05960 LipidMAPS: LMFA03010026, LMFA03110005 |
| C20H32O5 | 352.22497 | -0.077 | Narbonolide | KEGG: C11997 |
| C20H32O5 | 352.22497 | -0.077 | (5S,9R)-7,8-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid | LipidMAPS: LMFA03100009, LMFA03100010, LMFA03100011, LMFA03100012 |
| C20H32O5 | 352.22497 | -0.077 | 20-OH-Leukotriene B4 | HMDB: HMDB0001509, HMDB0245567 KEGG: C04853 LipidMAPS: LMFA03020018 |
| C20H32O5 | 352.22497 | -0.077 | LipidMAPS: LMPR0104180002 |
|
| C20H32O5 | 352.22497 | -0.077 | Lipoxin A4 | HMDB: HMDB0004385, HMDB0012587, HMDB0251839 KEGG: C06314 LipidMAPS: LMFA03040001, LMFA03040003, LMFA03040010 |
| C20H32O5 | 352.22497 | -0.077 | (ent-3beta,8beta,13Z)-3,8-Dihydroxy-17-oxo-13-labden-15-oic acid | KNApSAcK: C00022256 |
| C20H32O5 | 352.22497 | -0.077 | Membrenone B | KNApSAcK: C00039748 |
| C20H32O5 | 352.22497 | -0.077 | Flexibilolide | KNApSAcK: C00050099 |
| C20H32O5 | 352.22497 | -0.077 | (5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate | HMDB: HMDB0002776, HMDB0012481 KEGG: C04671 LipidMAPS: LMFA03010031 |
| C20H32O5 | 352.22497 | -0.077 | 5S,12,18S-trihydroxy-6Z,8E,14Z,16E-eicosatetraenoic acid | LipidMAPS: LMFA03140001 |
| C20H32O5 | 352.22497 | -0.077 | 17-Hydroxyacanthoaustralide | KNApSAcK: C00022029 |
| C20H32O5 | 352.22497 | -0.077 | 6beta,7beta,9alpha-Trihydroxy-8,13-epoxy-labd-14-en-11-one | KNApSAcK: C00022461 |
| C20H32O5 | 352.22497 | -0.077 | (11S,15R)-12,13-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid | LipidMAPS: LMFA03100029, LMFA03100030, LMFA03100031, LMFA03100032 |
| C20H32O5 | 352.22497 | -0.077 | Thromboxane A2 | HMDB: HMDB0001452 KEGG: C02198 LipidMAPS: LMFA03030001 |
| C20H32O5 | 352.22497 | -0.077 | 16S17S,18R-trihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid | LipidMAPS: LMFA03000031, LMFA03000032 |
| C20H32O5 | 352.22497 | -0.077 | Homalomenol F | KNApSAcK: C00033920 |
| C20H32O5 | 352.22497 | -0.077 | Diacarperoxide A | KNApSAcK: C00039002 |
| C20H32O5 | 352.22497 | -0.077 | Phyllostachysin E | KNApSAcK: C00034947 |
| C20H32O5 | 352.22497 | -0.077 | (R,5Z,9E)-8-hydroxy-10-((1S,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid | LipidMAPS: LMFA03110203, LMFA03110204, LMFA03110205, LMFA03110206, LMFA03110207, LMFA03110208, LMFA03110209, LMFA03110210, LMFA03110211, LMFA03110212, LMFA03110213, LMFA03110214, LMFA03110215, LMFA03110216, LMFA03110217, LMFA03110218 |
| C21H28ON4 | 352.22631 | -3.874 | 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-amine | HMDB: HMDB0251545 |
MSnスペクトル情報
| Level: 2, プリカーサーm/z: 353.23206 |
| Splash: splash10-000i-0009000000-211b8938ced30e97a14f |
| m/z | Int. | NL | Rel.Int. |
|---|---|---|---|
| 335.24 | 1166 | 18 | 1000 |
FlavonoidSearch結果
| Score | Symbolized Name | MSMS-Category | MSMS-Aglycone |
|---|---|---|---|
| 0.100 | [2'-Hydroxychalcone]-A(1OH, 1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH) | 2'-Hydroxychalcone | Xanthohumol C |
| 0.100 | [2'-Hydroxychalcone]-A(1OH, 1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH) | 2'-Hydroxychalcone | Citrunobin |
| 0.100 | [2'-Hydroxychalcone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH, 1OMe) | 2'-Hydroxychalcone | Pongachalcone II |
| 0.091 | [Flavanone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OMe) | Flavanone | 5-Hydroxy-4'-methoxy-6'',6''-dimethylpyrano[2'',3'':7,8]flavanone |
| 0.083 | [Flavone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(2OH) | Flavone | Cycloartocarpesin |
| 0.083 | [Flavone]-A(2OH)-B(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano))) | Flavone | Yinyanghuo E |
| 0.077 | [Isoflavone]-A(2OH)-B(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano))) | Isoflavone | Semilicoisoflavone B |
| 0.077 | [Isoflavone]-A(2OH)-B(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano))) | Isoflavone | Licoisoflavone B |
| 0.077 | [Isoflavone]-A(2OH)-B(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano))) | Isoflavone | Sophoraisoflavone A |
| 0.077 | [Isoflavone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(2OH) | Isoflavone | 5,3',4'-Trihydroxy-6'',6''-dimethylpyrano[2'',3'':7,6]isoflavone |
| 0.077 | [Isoflavone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(2OH) | Isoflavone | Parvisoflavone A |
| 0.077 | [Isoflavone]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(2OH) | Isoflavone | Parvisoflavone B |
| 0.071 | [2'-Hydroxychalcone]-A(1OH, 2OMe, 1(C-Prenyl))-B(none) | 2'-Hydroxychalcone | Ovalichalcone |
| 0.071 | [2'-Hydroxychalcone]-A(1OH, 1OMe, 1(C-Prenyl))-B(1OMe) | 2'-Hydroxychalcone | 4'-O-Methylbavachalcone |
| 0.067 | [Flavanone]-A(2OMe, 1(C-Prenyl))-B(none) | Flavanone | Candidone |
| 0.053 | [Flavonol]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH) | Flavonol | 3,5,4'-Trihydroxy-6'',6''-dimethylpyrano[2,3:7,6]flavone |
| 0.053 | [Flavonol]-A(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH) | Flavonol | Citrusinol |
| 0.045 | [Isoflavone]-A(1OH, 1OMe, 1(C-Prenyl))-B(1OH) | Isoflavone | Gancaonin G |
| 0.045 | [Isoflavone]-A(1OH, 1OMe, 1(C-Prenyl))-B(1OH) | Isoflavone | 5-O-Methyllupiwighteone |
| 0.045 | [Isoflavone]-A(2OH, 1(C-Prenyl))-B(1OMe) | Isoflavone | Gancaonin A |
| 0.045 | [Isoflavone]-A(2OH, 1(C-Prenyl))-B(1OMe) | Isoflavone | Gancanin M |
| 0.000 | [Flavone]-A(1OH, 1OMe, 1(C-Prenyl))-B(1OH) | Flavone | Artonin U |
| 0.000 | [Pterocarpan]-A(1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(1OH) | Pterocarpan | Edulenanol |
| 0.000 | [2'-Hydroxychalcone]-A(1OH, 1([2,3:@@]-(5,5-Dimethyl-4-hydroxy-4,5,3a,6a-tetrahydro-furo[2,3-b]furano)))-B(none) | 2'-Hydroxychalcone | Tephrosone |
| 0.000 | [2'-Hydroxychalcone]-A(1OH, 1OMe, 1([2,3:@@]-(4,5-Epoxy-6,6-dimethyl-4,5-dihydropyrano)))-B(none) | 2'-Hydroxychalcone | Epoxyobovatachalcone |
| 0.000 | [beta-Hydroxy(or Oxodihydro)chalcone]-A(1OH, 1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(none) | beta-Hydroxy(or Oxodihydro)chalcone | Demethylpraecanson B |
| 0.000 | [beta-Hydroxy(or Oxodihydro)chalcone]-A(2OMe, 1(C-Prenyl))-B(none) | beta-Hydroxy(or Oxodihydro)chalcone | Pongagallone A |
| 0.000 | [Flavanone]-A(1OH, 1(C-Prenyl))-B(1([@@]-Methylenedioxy)) | Flavanone | Ovaliflavanone C |
| 0.000 | [CCS-type derivative / [2',3]-Prenyloxidoflavone]-A(2OH)-B(1OH) | CCS-type derivative / [2',3]-Prenyloxidoflavone | Cyclocommunol |
| 0.000 | [Flavonol (3-OMe)]-A(2OMe, 1([2,3:@@]-Furano))-B(none) | Flavonol | 3,5,6-Trimethoxyfurano[2,3:7,8]flavone |
| 0.000 | [Flavan 4-ol (4-OMe)]-A(1OMe, 1([2,3:@@]-(5-Isopropenyldihydrofurano)))-B(none) | Flavan 4-ol | Methylhildgardtol A |
| 0.000 | [Flavan 4-ol (4-OMe)]-A(1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(none) | Flavan 4-ol | Methylhildgardtol B |
| 0.000 | [Flavan 4-ol (4-OMe)]-A(1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(none) | Flavan 4-ol | Xuulanin |
| 0.000 | [Isoflavone]-A(2OH)-B(1OH, 1([2,3:@@]-(5-Isopropenyldihydrofurano))) | Isoflavone | Crotarin |
| 0.000 | [Isoflavone]-A(1OH, 1([2,3:@@]-(5-Isopropenyldihydrofurano)))-B(2OH) | Isoflavone | Lupinisoflavone A |
| 0.000 | [Isoflavan]-A(1([@@]-Methylenedioxy))-B(1OH, 1([2,3:@@]-(6,6-Dimethylpyrano))) | Isoflavan | Leiocin |
| 0.000 | [isoflavene]-A(1OMe, 1([2,3:@@]-(6,6-Dimethylpyrano)))-B(2OH) | isoflavene | Neorauflavene |
| 0.000 | [Pterocarpan]-A(1OH, 1(C-Prenyl))-B(1([@@]-Methylenedioxy)) | Pterocarpan | Edunol |
| 0.000 | [Pterocarpan]-A(1([2,3:@@]-(6,6-Dimethyldihydropyrano)))-B(1([@@]-Methylenedioxy)) | Pterocarpan | Neorautane |
| 0.000 | [Coumestan]-A(1OH, 1(3-Methyl-2,3-epoxybutyl))-B(1OH) | Coumestan | Psoralidin oxide |
| 0.000 | [Coumestan]-A(1OH)-B(1([2,3:@@]-(5-(Hydroxyisopropanyl)dihydrofurano))) | Coumestan | Bavacoumestan B |
| 0.000 | [Coumestan]-A(1OH)-B(1([2,3:@@]-(6,6-Dimethyl-5-hydroxydihydropyrano))) | Coumestan | Bavacoumestan A |
| 0.000 | [Rotenone]-A(1([2,3:@@]-Furano))-B(2OMe) | Rotenone | Elliptone |
| 0.000 | [Rotenone]-A(1([2,3:@@]-Furano))-B(2OMe) | Rotenone | Erosone |
| 0.000 | [12a-Hydroxyrotenone]-A(1([2,3:@@]-Furano))-B(1([@@]-Methylenedioxy)) | 12a-Hydroxyrotenone | 12a-Hydroxydolineone |
| 0.000 | [Coumaranochromon]-A(2OH)-B(1OH, 1(C-Prenyl)) | Coumaranochromon | Lupinalbin D |
| 0.000 | [Coumaranochromon]-A(2OH, 1(C-Prenyl))-B(1OH) | Coumaranochromon | Lupinalbin B |